Complete genome sequence of Levilactobacillus brevis 47f: a potential pharmabiotic strain
Microbiology Resource Announcements · 13.01.2026 · 15 (1)
DOI: 10.1128/mra.00123-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Resource Announcements, erschienen am 13.01.2026. Verfasst von Tatiana Koshenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Levilactobacillus brevis 47f is a human-isolated strain known to possess antioxidant and antimucositic activities. We present the complete genome sequence of the strain L. brevis 47f, which consists of a circular chromosome (2,400,704 bp) and five plasmids.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.
ORCID-Profile: Tatiana Koshenko
Förderung
- Russian Science Foundation
Zitieren
APA
Koshenko, T., Poluektova, E., Yunes, R., Marsova, M., & Danilenko, V. (2026). Complete genome sequence of Levilactobacillus brevis 47f: a potential pharmabiotic strain. Microbiology Resource Announcements, 15(1). https://doi.org/10.1128/mra.00123-25
Vancouver
Koshenko T, Poluektova E, Yunes R, Marsova M, Danilenko V. Complete genome sequence of Levilactobacillus brevis 47f: a potential pharmabiotic strain. Microbiology Resource Announcements. 2026;15(1). doi:10.1128/mra.00123-25
BibTeX
@article{Koshenko2026,
author = {Koshenko, Tatiana and Poluektova, Elena and Yunes, Roman and Marsova, Maria and Danilenko, Valery},
title = {Complete genome sequence of Levilactobacillus brevis 47f: a potential pharmabiotic strain},
journal = {Microbiology Resource Announcements},
year = {2026},
volume = {15},
number = {1},
doi = {10.1128/mra.00123-25}
}
EUVIMED